Press Release: European Medicines Agency recommends approval of first vaccine for meningitis B

Awdur (Corfforaethol)
Teitl y Gyfres
Manylion y Gyfres EMA/CHMP/728052/2012 (16.11.12)
Dyddiad Cyhoeddi 16/11/2012
Math o Gynnwys

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP), in November 2012, recommended the granting of a marketing authorisation for Bexsero, a new vaccine intended for the immunisation of individuals over two months of age against invasive meningococcal disease caused by Neisseria meningitidis group B.

The applicant for Bexsero is Novartis.
Dolen Ffynhonnell Link to Main Source http://www.emea.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2012/11/news_detail_001656.jsp&mid=WC0b01ac058004d5c1
Dolenni Cysylltiedig
EMA: Press Release: EMA/CHMP/728052/2012 (16.11.12) http://www.emea.europa.eu/docs/en_GB/document_library/Press_release/2012/11/WC500134846.pdf
Categorïau Pwnc
Gwledydd / Rhanbarthau